CALGARY, Alberta, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Bien Ventures Ltd. (“Bien”) is pleased to announce that it is to establish a cannabis derivatives manufacturing facility in Calgary, Alberta, subject to licensing by Health Canada and municipal approval.
The existing facility includes a fully-equipped prototyping lab with comprehensive testing capabilities through which Bien aims to develop proprietary formulations of nanoemulsions and powdered forms of CBD, THC and a wide range of other organic loads such as terpenes. Bien’s products will focus on rapid effect onset, enhanced bioavailability, discreet delivery, consistency and stability.
Bien has submitted an ACMPR Licensed Producer application to Health Canada in compliance with the expected future requirements for a Standard Processing Licence.
Bien has also commenced discussions with Canadian Licensed Producers and food and beverage brands that plan to bring cannabis edibles and beverages to market when the regulations for such products are set by Health Canada.
For more information please contact:
Andrew Wong, CSO
Telephone: 1-403-472-0549
Email: info@bienbrands.com
About Bien
Bien is focused on the research, development and pharmaceutical-grade manufacturing of next-generation cannabis products for infusion or direct consumption with an emphasis on tailoring dosage, onset time, duration and bioavailability profiles. Balancing academia and industry, our team of technical experts is dedicated to continually improving our processes and formulations to bring best-in-class input solutions for those wanting to develop or improve their existing cannabis product portfolio.